View in EDS

Prediction of Benefit From Adjuvant Pertuzumab by 80-Gene Signature in the APHINITY (BIG 4-11) Trial.

Saved in:
Bibliographic Details
Title: Prediction of Benefit From Adjuvant Pertuzumab by 80-Gene Signature in the APHINITY (BIG 4-11) Trial.
Authors: Krop IE; Yale Cancer Center, New Haven, CT., Mittempergher L; Agendia, Amsterdam, the Netherlands., Paulson JN; Genentech, San Francisco, CA., Andre F; Gustave Roussy, Paris, France., Bonnefoi H; Bergonie Cancer Institute, Bordeaux, France., Loi S; Peter MacCallum Cancer Centre, Melbourne, Australia., Loibl S; Goethe University, Frankfurt, Germany., Gelber RD; Dana-Farber Cancer Institute, Harvard Medical School, Harvard TH Chan School of Public Health, and Frontier Science Foundation, Boston, MA., Caballero C; Breast International Group (BIG), Brussels, Belgium., Bhaskaran R; Agendia, Amsterdam, the Netherlands., Dreezen C; Agendia, Amsterdam, the Netherlands., Menicucci AR; Agendia, Amsterdam, the Netherlands., Bernards R; Agendia, Amsterdam, the Netherlands., van 't Veer LJ; Agendia, Amsterdam, the Netherlands., Piccart MJ; Breast International Group (BIG), Brussels, Belgium.
Source: JCO precision oncology [JCO Precis Oncol] 2024 Jan; Vol. 8, pp. e2200667.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38237097
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Prediction of Benefit From Adjuvant Pertuzumab by 80-Gene Signature in the APHINITY (BIG 4-11) Trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Krop+IE%22">Krop IE</searchLink>; Yale Cancer Center, New Haven, CT.<br /><searchLink fieldCode="AU" term="%22Mittempergher+L%22">Mittempergher L</searchLink>; Agendia, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Paulson+JN%22">Paulson JN</searchLink>; Genentech, San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Andre+F%22">Andre F</searchLink>; Gustave Roussy, Paris, France.<br /><searchLink fieldCode="AU" term="%22Bonnefoi+H%22">Bonnefoi H</searchLink>; Bergonie Cancer Institute, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Loi+S%22">Loi S</searchLink>; Peter MacCallum Cancer Centre, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Loibl+S%22">Loibl S</searchLink>; Goethe University, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Gelber+RD%22">Gelber RD</searchLink>; Dana-Farber Cancer Institute, Harvard Medical School, Harvard TH Chan School of Public Health, and Frontier Science Foundation, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Caballero+C%22">Caballero C</searchLink>; Breast International Group (BIG), Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Bhaskaran+R%22">Bhaskaran R</searchLink>; Agendia, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Dreezen+C%22">Dreezen C</searchLink>; Agendia, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Menicucci+AR%22">Menicucci AR</searchLink>; Agendia, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Bernards+R%22">Bernards R</searchLink>; Agendia, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22van+'t+Veer+LJ%22">van 't Veer LJ</searchLink>; Agendia, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Piccart+MJ%22">Piccart MJ</searchLink>; Breast International Group (BIG), Brussels, Belgium.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101705370%22">JCO precision oncology</searchLink> [JCO Precis Oncol] 2024 Jan; Vol. 8, pp. e2200667.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Clinical+Oncology%22">American Society of Clinical Oncology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101705370 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2473-4284 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224734284%22">24734284 </searchLink><i>NLM ISO Abbreviation: </i>JCO Precis Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38237097
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1200/PO.22.00667
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e2200667
    Titles:
      – TitleFull: Prediction of Benefit From Adjuvant Pertuzumab by 80-Gene Signature in the APHINITY (BIG 4-11) Trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Krop IE
      – PersonEntity:
          Name:
            NameFull: Mittempergher L
      – PersonEntity:
          Name:
            NameFull: Paulson JN
      – PersonEntity:
          Name:
            NameFull: Andre F
      – PersonEntity:
          Name:
            NameFull: Bonnefoi H
      – PersonEntity:
          Name:
            NameFull: Loi S
      – PersonEntity:
          Name:
            NameFull: Loibl S
      – PersonEntity:
          Name:
            NameFull: Gelber RD
      – PersonEntity:
          Name:
            NameFull: Caballero C
      – PersonEntity:
          Name:
            NameFull: Bhaskaran R
      – PersonEntity:
          Name:
            NameFull: Dreezen C
      – PersonEntity:
          Name:
            NameFull: Menicucci AR
      – PersonEntity:
          Name:
            NameFull: Bernards R
      – PersonEntity:
          Name:
            NameFull: van 't Veer LJ
      – PersonEntity:
          Name:
            NameFull: Piccart MJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2024 Jan
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2473-4284
          Numbering:
            – Type: volume
              Value: 8
          Titles:
            – TitleFull: JCO precision oncology
              Type: main
ResultId 1